PATENT CLAIM ANALYSIS

Application Number: 15984028
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "178000"]

Abstract:
Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum plasma testosterone levels over an extended period.

Claim (Index 21):
The method of  claim 1 , wherein the oral pharmaceutical composition comprises about 19.8 percent by weight of solubilized testosterone undecanoate, about 51.6 percent by weight of oleic acid, about 16.1 percent by weight of polyoxyethylene (40) hydrogenated castor oil, about 10 percent by weight of borage seed oil, about 2.5 percent by weight of peppermint oil, and about 0.03 percent by weight of butylated hydroxytoluene (BHT).

Metadata:
- Claim Count in Document: 71.0
- Percentile: 93.0
- Lexical Diversity: 1.21429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12758770', '13584958', '15107492', '15723985', '14691229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.820134187994675
- 35 USC 102 Novelty (BERT): 0.5520964794244152
- Combined Prediction Score: 0.7933304171376491
- Mean Citation Score: 385.839508
- Max Citation Score: 404.2631
- Similarity Product: 374.989136916846

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test